ANTI-HER2-ANTIKÖRPERFORMULIERUNG

European patent · EP2934582 · Deleted

Register entry

Publication number
EP2934582
Application number
EP13808043
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 18, 2013
Published
Oct 28, 2015
Granted
Nov 27, 2019
Deleted
Jul 25, 2023
Reason
Annual fee unpaid
IPC classes
A61K 39/395 (2006.01)
C07K 16/32 (2006.01)
Priority
US 201261745293 P 21.12.2012
PCT application
PCT/EP2013/077166 18.12.2013
PCT publication
WO2014/096051 26.06.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 25, 2023

    Deleted, fee unpaid

    Published in Swissreg on 25.07.2023

  2. Feb 14, 2020

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 14.02.2020

  3. Feb 12, 2020

    Owner

    Owner
    Glenmark Pharmaceuticals S.A., Chemin de la Combeta, 5, 2300 La Chaux-de-Fonds → Ichnos Sciences SA, Chemin de la Combeta 5, 2300 La Chaux-de-Fonds

    Published in Swissreg on 12.02.2020

  4. Nov 27, 2019

    Granted

    Published in Swissreg on 27.11.2019

Parties

Holder

IGI Therapeutics SA

Ichnos Sciences SA

Chemin de la Combeta 5, 2300 La Chaux-de-Fonds

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

ALBANESE, Jonathan André

CH-2300 La Chaux-de-Fonds

O'MAHONY, Kevin Niall

CH-2300 La Chaux-de-Fonds

GIOVANNINI, Roberto Pier-Lorenzo

CH-2300 La Chaux-de-Fonds

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.